MDSC: a new player in HIV immunopathogenesis

Editorial

Bernard J C Macatangay et al. AIDS. 2012.

. 2012 Jul 31;26(12):1567-9.

doi: 10.1097/QAD.0b013e328355e682.

No abstract available

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells.
Vollbrecht T, Stirner R, Tufman A, Roider J, Huber RM, Bogner JR, Lechner A, Bourquin C, Draenert R. Vollbrecht T, et al. AIDS. 2012 Jul 31;26(12):F31-7. doi: 10.1097/QAD.0b013e328354b43f. AIDS. 2012. PMID: 22526518

1. Young MR, Newby M, Wepsic HT. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 1987;47:100–105. - PubMed
1. Filipazzi P, Huber V, Rivoltini L. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother. 2012;61:255–263. - PMC - PubMed
1. Pak AS, Wright MA, Matthews JP, Collins SL, Petruzzelli GJ, Young MR. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin Cancer Res. 1995;1:95–103. - PubMed
1. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nature reviews Immunology. 2009;9:162–174. - PMC - PubMed
1. Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol. 2004;172:989–999. - PubMed